{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:47:39Z","timestamp":1761864459544,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T00:00:00Z","timestamp":1662249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T00:00:00Z","timestamp":1662249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00270-022-03259-z","type":"journal-article","created":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T16:02:15Z","timestamp":1662307335000},"page":"1855-1859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Methodology of the BIOPACT RCT, a Multi-center, Randomized, Non-inferiority Trial Evaluating Safety and Efficacy of Passeo-18 Lux Drug-Coated Balloon (DCB) of Biotronik Compared to the Medtronic IN.PACT Admiral DCB in the Treatment of Subjects with Lesions of the Femoropopliteal Artery"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-7323","authenticated-orcid":false,"given":"Koen","family":"Deloose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Lansink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Keirse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Gou\u00ebffic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Verbist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieven","family":"Maene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Ducasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Levent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Sauguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"D\u00e9glise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"Vandael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,4]]},"reference":[{"issue":"1","key":"3259_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1526602814564383","volume":"22","author":"D Scheinert","year":"2015","unstructured":"Scheinert D, Schulte KL, Zeller T, Lammer J, Tepe G. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: Twelve-month results from the BIOLUX P-I randomized trial. J Endovascr Ther. 2015;22(1):14\u201321. https:\/\/doi.org\/10.1177\/1526602814564383.","journal-title":"J Endovascr Ther"},{"issue":"10","key":"3259_CR2","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00270-017-1713-2","volume":"40","author":"G Tepe","year":"2017","unstructured":"Tepe G, G\u00f6gebakan \u00d6, Redlich U, Tautenhahn J, Ricke J, Halloul Z, et al. Angiographic and clinical outcomes after treatment of femoro-popliteal lesions with a novel paclitaxel-matrix-coated balloon catheter. CardioVasc Interven Radiol. 2017;40(10):1535\u201344. https:\/\/doi.org\/10.1007\/s00270-017-1713-2.","journal-title":"CardioVasc Interven Radiol"},{"issue":"23","key":"3259_CR3","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"H Schroeder","year":"2022","unstructured":"Schroeder H, Werner M, Meyer DR, Reimer P, Kr\u00fcger K, Jaff MR, et al. Circulation. 2022;135(23):2227\u201336.","journal-title":"Circulation"},{"issue":"2","key":"3259_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ccd.25900","volume":"86","author":"H Schroeder","year":"2015","unstructured":"Schroeder H, Meyer DR, Lux B, Ruecker F, Martorana M, Duda S. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first-in-human study. Cathete Cardiovasc. 2015;86(2):278\u201386. https:\/\/doi.org\/10.1002\/ccd.25900.","journal-title":"Cathete Cardiovasc"},{"issue":"12","key":"3259_CR5","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","volume":"136","author":"P Krishnan","year":"2017","unstructured":"Krishnan P, Faries P, Niazi K, Jain A, Sachar R, Bachinsky WB, et al. Stellarex drug-coated balloon for treatment of femoropopliteal disease: Twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies. Circulation. 2017;136(12):1102\u201313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028893.","journal-title":"Circulation"},{"issue":"5","key":"3259_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131(5):495\u2013502. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011004.","journal-title":"Circulation"},{"key":"3259_CR7","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","volume":"66","author":"JR Laird","year":"2015","unstructured":"Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, et al. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol. 2015;66:2329\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3259_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1526602817745565","volume":"25","author":"O Iida","year":"2018","unstructured":"Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, et al. Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial. J Endovasc Ther. 2018;25(1):109\u201317. https:\/\/doi.org\/10.1177\/1526602817745565.","journal-title":"J Endovasc Ther"},{"issue":"2","key":"3259_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1406235","volume":"373","author":"K Rosenfield","year":"2015","unstructured":"Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. New England J Med. 2015;373(2):145\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1406235.","journal-title":"New England J Med"},{"issue":"1","key":"3259_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","volume":"7","author":"D Scheinert","year":"2014","unstructured":"Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization. JACC Cardiovasc Interv. 2014;7(1):10\u20139. https:\/\/doi.org\/10.1016\/j.jcin.2013.05.022.","journal-title":"JACC Cardiovasc Interv"},{"key":"3259_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.04.041","author":"M Thieme","year":"2017","unstructured":"Thieme M, von Bilderling P, Paetzel C, Karnabatidis D, Perez Delgado J, Lichtenberg M. The 24-month results of the lutonix\u00a0global SFA registry. JACC: Cardiovasc Interv. 2017. https:\/\/doi.org\/10.1016\/j.jcin.2017.04.041.","journal-title":"JACC: Cardiovasc Interv"},{"issue":"3","key":"3259_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jcin.2013.01.128","volume":"6","author":"A Micari","year":"2013","unstructured":"Micari A, Cioppa A, Vadal\u00e0 G, Castriota F, Liso A, Marchese A, et al. 2-Year results of paclitaxel-eluting balloons for femoropopliteal artery disease. JACC: Cardiovasc Interv. 2013;6(3):282\u20139. https:\/\/doi.org\/10.1016\/j.jcin.2013.01.128.","journal-title":"JACC: Cardiovasc Interv"},{"issue":"4","key":"3259_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/1526602817710770","volume":"24","author":"Y Bausback","year":"2017","unstructured":"Bausback Y, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, del Giudice C, et al. Six-month results from the initial randomized study of the ranger paclitaxel-coated balloon in the femoropopliteal segment. J Endovasc Therapy. 2017;24(4):459\u201367. https:\/\/doi.org\/10.1177\/1526602817710770.","journal-title":"J Endovasc Therapy"},{"key":"3259_CR14","first-page":"715","volume":"9","author":"A Schmidt","year":"2016","unstructured":"Schmidt A, Piorkowski M, G\u00f6rner H, Steiner S, Bausback Y, Scheinert S, et al. Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry. JACC: Cardiovascular Interv. 2016;9:715\u201324.","journal-title":"JACC: Cardiovascular Interv"},{"issue":"3","key":"3259_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1583\/13-4630MR.1","volume":"21","author":"T Zeller","year":"2014","unstructured":"Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, et al. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Therapy. 2014;21(3):359\u201368. https:\/\/doi.org\/10.1583\/13-4630MR.1.","journal-title":"J Endovasc Therapy"},{"issue":"1","key":"3259_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.23736\/S0021-9509.17.10261-2","volume":"59","author":"M Lichtenberg","year":"2017","unstructured":"Lichtenberg M, von Bilderling P, Ranft J, Niemoller K, Grell H, Briner L, et al. Treatment of femoropopliteal atherosclerotic lesions using the ranger paclitaxel-coated balloon catheter: 12-month results from an all-comers registry. J Cardiovasc Surg. 2017;59(1):45\u201350.","journal-title":"J Cardiovasc Surg"},{"key":"3259_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ahj.2018.12.012","volume":"209","author":"S Elmariah","year":"2019","unstructured":"Elmariah S, Ansel GM, Brodmann M, Doros G, Fuller S, Gray WA, et al. Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery \u2014 the TRANSCEND study. American Heart J Mosby. 2019;209:88\u201396.","journal-title":"American Heart J Mosby"},{"issue":"27","key":"3259_CR18","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehaa049","volume":"41","author":"S Steiner","year":"2020","unstructured":"Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, et al. COMPARE: prospective, randomized, non-inferiority trial of high- vs low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. European Heart J. 2020;41(27):2541\u201352.","journal-title":"European Heart J"},{"key":"3259_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011245","author":"K Katsanos","year":"2018","unstructured":"Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: A systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018. https:\/\/doi.org\/10.1161\/JAHA.118.011245.","journal-title":"J Am Heart Assoc"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03259-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03259-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03259-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T17:19:08Z","timestamp":1669655948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-022-03259-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,4]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3259"],"URL":"https:\/\/doi.org\/10.1007\/s00270-022-03259-z","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"type":"print","value":"0174-1551"},{"type":"electronic","value":"1432-086X"}],"subject":[],"published":{"date-parts":[[2022,9,4]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Deloose has received research grants from BIOTRONIK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}